In juvenile RA, levels of calprotectin and S100A12 are strongly influenced by disease activity and systemic therapy [64], and S100A12 proved to be the best single predictor of disease flare-up after the withdrawal of therapy [65]. The gene discussed is S100A12; the disease is rheumatoid arthritis.